Bendamustine Plus Rituximab Followed By Rituximab Maintenance for Patients with Untreated Advanced Follicular Lymphomas. Results from the StiL NHL 7-2008 Trial (MAINTAIN trial) (ClinicalTrials.gov Identifier: NCT00877214)Mathias Rummel, Wolfram Brugger, Christian Lerchenmüller et al.|Blood|2014Cited by 7
Four versus Two Years of Rituximab Maintenance (R-Maintenance) Following Bendamustine Plus Rituximab (B-R): Results of a Prospective, Randomized Multicenter Phase 3 Study in First-Line Follicular Lymphoma (the StiL NHL7-2008 MAINTAIN Study)Mathias Rummel, Richard Greil, Christian Buske et al.|Clinical Lymphoma Myeloma & Leukemia|2018Cited by 6